Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...
A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Investing.com -- Fitch Ratings has revised its outlook for biopharmaceutical company Amgen Inc (NASDAQ: AMGN ). to positive ...
12h
MedPage Today on MSNWill Medicare Price Negotiations Really Cut Rheum Drug Costs?Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...
Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...
Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...
19h
TipRanks on MSNAkari Therapeutics Appoints New CEO Abizer GaslightwalaAkari Therapeutics ( ($AKTX) ) has issued an announcement. On March 14, 2025, Akari Therapeutics announced the appointment of Mr. Abizer ...
Zenas BioPharma (ZBIO) stock rises as Wedbush issues a bullish recommendation based on the company's lead asset obexelimab. Read more here.
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results